SLEEK OTW PTA CATHETER

K130786 · C.R. Bard, Inc. · LIT · May 3, 2013 · Cardiovascular

Device Facts

• Record ID: K130786
• Device Name: SLEEK OTW PTA CATHETER
• Applicant: C.R. Bard, Inc.
• Product Code: LIT · Cardiovascular
• Decision Date: May 3, 2013
• Decision: SESE
• Submission Type: Special
• Regulation: 21 CFR 870.1250
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The Sleek® OTW PTA Catheters are intended for balloon dilatation of the femoral, popliteal and infra-popliteal arteries. These catheters are not designed to be used in the coronary arteries.

Device Story

Sleek® OTW PTA Catheter LE is a balloon dilation catheter for percutaneous transluminal angioplasty. Device features double lumen coaxial shaft with inflatable distal balloon; proximal double hub connector allows inflation device attachment and guidewire advancement through distally open inner lumen. Used by physicians in clinical settings to dilate peripheral arteries. Output is mechanical dilation of stenotic vessels; clinical benefit includes improved blood flow in femoral, popliteal, and infra-popliteal arteries.

Clinical Evidence

Bench testing only. No clinical data provided. Performance evaluated via in vitro testing including balloon working length, marker band alignment, burst strength, burst mode, proximal tensile, sheath compatibility, reinsertion, inflation/deflation time, fatigue, balloon outer diameter, and compliance.

Technological Characteristics

Double lumen coaxial shaft; balloon and outer shaft made of Polyamide; inner shaft made of HDPE/Plexar/PolyEther Block Amide; Polycarbonate hub; PolyEther Block Amide strain relief. Mechanical dilation principle. Non-powered. Sterilized device.

Indications for Use

Indicated for balloon dilatation of femoral, popliteal, and infra-popliteal arteries. Contraindicated for use in coronary arteries.

Regulatory Classification

Identification

A percutaneous catheter is a device that is introduced into a vein or artery through the skin using a dilator and a sheath (introducer) or guide wire.

Predicate Devices

• Sleek® OTW Percutaneous Transluminal Angioplasty (PTA) Catheter (K102035)

Submission Summary (Full Text)

{0}------------------------------------------------

K130786 p. 1 of 3

### Sleek® OTW PTA Catheters

#### 510(k) Summary

#### 21 CFR 807.92

As required by the Safe Medical Devices Act of 1990, coded under Section 513, Part (I)(3)(A) of the Food, Drug and Cosmetic Act, a summary of the information upon which substantial equivalence determination is based as follows:

#### 1. Submitter Information:

, محب

| Applicant: | ClearStream Technologies Ltd.<br>Moyne Upper,<br>Enniscorthy,<br>Co. Wexford,<br>Ireland. |
|------------|-------------------------------------------------------------------------------------------|
| Phone: | [phone] |
| Fax: | + 353 53 9237100 |
| Contact: | Fiona Ní Mhulláin, Senior RA/QA Manager |
| Date: | 20 March 2013 |

#### 2. Subject Device:

| Device Trade Name: | Sleek ® OTW PTA Catheters |
|-----------------------|--------------------------------------------------------------|
| Common or Usual Name: | Percutaneous Catheter (21 CFR 870.1250, Product<br>Code LIT) |
| Classification: | Class II |
| Classification Panel: | Cardiovascular |

#### 3. Predicate Device:

| Device Trade Name: | Sleek® OTW Percutaneous Transluminal Angioplasty<br>(PTA) Catheter |
|-------------------------|--------------------------------------------------------------------|
| Cleared 510(K) Number: | K102035 |
| Date of Cleared 510(K): | 01-Dec-10 |

#### 4. Summary of Change:

The only difference between the predicate device, the Sleek® OTW PTA Catheter, and the subject device, the Sleek® OTW PTA Catheter LE, were the addition of balloon lengths.

{1}------------------------------------------------

#### 5. Device Description:

The subject device, the Sleek® OTW PTA Catheter LE, is a balloon dilation catheter for angioplasty. A double lumen coaxial shaft features an inflatable balloon at its distal end. The proximal end provides a double hub connector, whose first port allows the attachment of an inflation device which is used to inflate and deflate the balloon through the outer lumen. A second hub port allows the advance of a guidewire throughout the whole length of the catheter using the distally open inner lumen.

The outer shaft lumen and the balloon are made of Polyamide, enclosing the inner High Density Polyethylene (HDPE) / Plexar / PolyEther Block Amide shaft. A Polycarbonate hub is connected to the outer and inner shaft proximally together with a PolyEther Block Amide strain relief tube.

#### 6. Indications for Use of Device:

The Sleek® OTW PTA Catheters are intended for balloon dilatation of the femoral, popliteal and infra-popliteal arteries. These catheters are not designed to be used in the coronary arteries.

#### 7. Technological Comparison to Predicate Device:

The technological characteristics of the subject device, the Sleek® OTW PTA Catheter LE, are equivalent to those of the predicate device (Sleek® OTW PTA Catheter. K102035), in terms of intended use, indications for use, materials, fundamental scientific technology, target population, operating principle, packaging, sterility assurance level, and method of sterilization.

#### 8. Performance Data:

To demonstrate the substantial equivalence of the subject device, the Sleek® OTW PTA Catheter LE, to the predicate device, its technological characteristics and performance criteria were evaluated. Using FDA Guidance Documents on nonclinical testing of medical devices and internal Risk Assessment procedures, the following additional in vitro tests were performed:

- . Balloon Working Length
- Marker Band Alignment .
- . Burst Strength (Rated Burst Pressure)
- . Burst Mode
- . Proximal Tensile

{2}------------------------------------------------

K130786 p. 3 of 3

- Sheath Compatibility .
- Reinsertion .
- Inflation Time .
- . Deflation Time
- . Fatigue
- Balloon Outer Diameter .
- Compliance .

The results from these tests demonstrate that the technological characteristics and performance criteria of the subject Sleek® OTW PTA Catheter LE is comparable to the predicate device.

#### 9. Conclusions:

The Sleek® OTW PTA Catheter LE met all predetermined acceptance criteria of design verification and validation as specified by applicable standards, guidance, test protocols, and/or customer inputs. The Sleek® OTW PTA Catheter LE is substantially equivalent to the legally marketed predicate device, the Sleek® OTW PTA Catheter.

{3}------------------------------------------------

DEPARTMENT OF HEALTH & HUMAN SERVICES

Image /page/3/Picture/1 description: The image shows the seal of the Department of Health & Human Services - USA. The seal is circular and contains the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. In the center of the seal is a stylized image of a caduceus, a symbol of medicine and health. The caduceus is depicted with a staff and two snakes winding around it.

Public Health Service

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

May 3, 2013

ClearStream Technologies, Ltd. c/o Ms. Fiona Ní Mhullain Senior RA/QA Manager Moyne Upper Enniscorthy County Wexford, Ireland

Re: K130786

Trade/Device Name: Sleek OTW PTA Catheters Line Extension Regulation Number: 21 CFR 870.1250 Regulation Name: Percutaneous catheter Regulatory Class: Class II Product Code: LIT Dated: April 3, 2013 Received: April 5, 2013

Dear Ms. Fiona Ní Mhullain:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set

{4}------------------------------------------------

#### Page 2 - Ms. Fiona Ní Mhullain

forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its tollfree number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number [phone] or [phone] or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.

Sincerely yours,

## Bram D. Zookerman

Bram D. Zuckerman, M.D. Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health

{5}------------------------------------------------

#### Indications for Use Statement

510(k) Number (if known): K130786

Device Name: Sleek® OTW Percutaneous Transluminal Angioplasty Catheter

The Sleek® OTW PTA Catheters are intended for balloon Indications for Use: dilatation of the femoral, popliteal and infra-popliteal arteries. These catheters are not designed to be used in the coronary arteries.

Prescription Use X (Part21 CFR 801 Subpart D) AND/OR

Over-The-Counter Use (21CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

# 201

ream Technologies Ltd.

Image /page/5/Picture/13 description: The image shows the word "clearStream" in a cursive font. There is a line above the word and a thicker line below the word. The word is written in black ink on a white background. The image is a logo or brand name.